Pre-Transplant Testing

Comprehensive solutions for the start of the transplant journey

Regulated testing for the transplant community for all donor suitability and eligibility determination requirements. Expert knowledge and support for your critical donor decisions where you need them when you need them.

High complexity testing laboratories offer Donor Eligibility Screening, HLA/Immunogenetics and Microbiology Testing, using the most appropriate regulated testing technologies for the transplant and medical communities. Robust Quality Program- FDA-registered for HCT/Ps, certifications, licenses, and accreditation’s for CLIA, State Agencies, ASHI, Therapeutic Goods Administrations (TGA), German Health Authority.

  • Complete test menu of infectious disease testing for donor screening. All required regulated testing needed for both deceased and living donor eligibility determination.
  • Robust Quality Program- FDA-registered for HCT/Ps, certifications, licenses and accreditation’s for CLIA, State Agencies and ASHI.
  • Regional testing laboratories; Denver, CO, Atlanta, GA, Boston, MA, Cincinnati, OH, Dallas, TX, Honolulu, HI, Los Angeles, CA, Minneapolis, MN, Philadelphia, PA, San Ramon, CA and Winston-Salem, NC.
  • 24/7/365 dedicated customer testing support.
  • STAT and routine testing for expedited results.
  • Result delivery to accommodate your needs: email, information system interface and portal.

Donor Screening Testing-Supporting critical donor screening testing to support your donor to transplant needs

Infectious disease testing by serological and nucleic acid methodologies for HIV, Hepatitis B and C. Analyzed pathogens depend on the tissue or cells tested as prescribed by 21 CFR 1271. A part from HIV and Hepatitis testing that are routinely performed in all donors, additional screening may include West Nile Virus, EBV, Chagas, Strongyloides, Toxoplasmosis, Human T-lymphotropic virus and Cytomegalovirus (CMV).

HLA Typing: A close Match between a donor’s and a recipient’s HLA markers is essential for a successful transplant outcome.

Human Leukocyte Antigen (HLA) testing is used to successfully match organ transplant recipients with compatible donors. Matching of the donor antigens in the recipient improves long-term graft survival and lowers rejection rates as well as incidents of infection due to decreased use of immunosuppression.

Clinical microbiology- a key role in diagnosis, treatment and prevention of these complications. supported with a well developed laboratory with special emphasis in rapid diagnostic techniques.

Satisfy regulatory agency requirements, cultures of the human cellular and tissue product are taken prior to the process, during the process and at final release of the product. Reduce and eliminate microorganisms that would compromise the recipient of the transplant. Consultive services to ensure that the appropriate testing methodology is used.

Want to learn more about pre-transplant testing?